Penicillin slows devastating impacts of rheumatic heart disease in children from Uganda

“Penicillin, a widely available and affordable antibiotic, may be one key to turning the tide on the deadly impacts of rheumatic heart disease (RHD) for children in developing nations. This according to the new findings of a large-scale, randomized controlled trial completed in Uganda and published in the New England Journal of Medicine.”

Previous
Previous

AHA: Penicillin Prophylaxis Effective in Preventing Progression of Latent Rheumatic Heart Disease

Next
Next

When an untreated infection leads to heart valve disease